SCHOTT Pharma
Dr. Leon Zwiener is an accomplished chemist with extensive experience in quality control and laboratory management, currently serving as Quality Control Manager and Laboratory Manager at SCHOTT Pharma since August 2022. Dr. Zwiener's career includes previous roles at SCHOTT as Quality Control Manager and Quality Engineer, as well as a postdoctoral researcher at Fritz-Haber-Institut der Max-Planck-Gesellschaft, where expertise in inorganic chemistry and heterogeneous catalysis was developed. Dr. Zwiener holds multiple degrees in chemistry, including a Dr. rer. nat. from Fritz-Haber-Institut der Max-Planck-Gesellschaft and Technische Universität Berlin, a Master of Science from The University of Freiburg, and a Bachelor of Science from The University of Freiburg. Teaching experience was gained at various departments within The University of Freiburg, focusing on inorganic chemistry and supporting students in practical courses.
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social